The store will not work correctly when cookies are disabled.
4-[6-Amino-5-(4-methylphenyl)pyridin-3-yl]benzoic acid
ID: ALA4741486
PubChem CID: 162646873
Max Phase: Preclinical
Molecular Formula: C19H16N2O2
Molecular Weight: 304.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2cc(-c3ccc(C(=O)O)cc3)cnc2N)cc1
Standard InChI: InChI=1S/C19H16N2O2/c1-12-2-4-14(5-3-12)17-10-16(11-21-18(17)20)13-6-8-15(9-7-13)19(22)23/h2-11H,1H3,(H2,20,21)(H,22,23)
Standard InChI Key: FIQWVTHFTDRJMB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
6.1977 -17.0949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1965 -17.9145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9046 -18.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6142 -17.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6114 -17.0913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9028 -16.6861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3191 -18.3207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3190 -19.1390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0265 -19.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7346 -19.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7307 -18.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0226 -17.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3176 -16.6801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4904 -18.3228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7827 -17.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0752 -18.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0741 -19.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7865 -19.5463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4911 -19.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3635 -19.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6556 -19.1397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3640 -20.3651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4435 -19.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 14 1 0
20 21 1 0
20 22 2 0
17 20 1 0
10 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.35 | Molecular Weight (Monoisotopic): 304.1212 | AlogP: 4.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.21 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.02 | CX Basic pKa: 7.03 | CX LogP: 2.29 | CX LogD: 1.78 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -0.37 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |